Mazda plans to stop making cars in US

Mazda Motor plans to leave its joint venture with Ford Motor and stop building cars in the United States, the Nikkei financial daily reported Friday.

Mazda and Ford operate the AutoAlliance International plant in Michigan as a 50-50 partnership. Citing unnamed company sources, the Nikkei said Mazda is considering selling its stake to Ford as the Japanese automaker tries to restructure its global production.

Mazda cars sold in the US will be shipped from Japan and Mexico starting around 2013, according to the Nikkei.

In response, Mazda issued a short statement saying the report was not based on information it had released.

“Mazda and Ford are jointly studying various possibilities for AAI, and we have nothing to announce at this time,” Mazda said. “We do not comment on speculation.”


The plant in Flat Rock, Michigan manufactures the Mazda6 midsize sedan and the Ford Mustang. It employs about 1 700 workers, according to Ford.

The US automaker has essentially agreed to maintain current worker levels by expanding the models it builds at the facility, Nikkei said.

The two companies loosened their longtime auto alliance last year when Ford cuts its stake in Mazda from 11% to 3.5%. At the time, Mazda President Takashi Yamanouchi insisted that the two companies would continue to cooperate through joint ventures and technology exchanges.

Mazda’s latest financial results revealed tough times for the Hiroshima-based company.

Its net losses swelled to 60-billion yen ($742-million) in the fiscal year ended March 31, from 6.5-billion yen the previous year. The company blamed a persistently strong yen and lacklustre sales in Japan, as well as the March 11 earthquake and tsunami that disrupted auto production. — Sapa-AP

Subscribe to the M&G

These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever.

The Mail & Guardian is a proud news publisher with roots stretching back 35 years, and we’ve survived right from day one thanks to the support of readers who value fiercely independent journalism that is beholden to no-one. To help us continue for another 35 future years with the same proud values, please consider taking out a subscription.

Related stories

Catholic NGO boss accused of racism and abuse in Sudan

The aid worker allegedly called his security guard a ‘slave’

Fake trafficking news targets migrants

Exaggerated reports on social media of human trafficking syndicates snatching people in broad daylight legitimate xenophobia while deflecting from the real problems in society

How US foreign policy under Donald Trump has affected Africa

Lesotho has been used as a microcosm in this article to reflect how the foreign policy has affected Africa

The challenges of delivering a Covid-19 vaccine in Africa requires a new approach

It is imperative that we train healthcare workers and participate in continent-wide collaboration

Spain detains software creator McAfee wanted in US

The announcement of his arrest comes a day after US prosecutors released an indictment against McAfee for allegedly failing to report income

Richard Calland: South Africa needs a Roosevelt style of leadership

President Cyril Ramaphosa needs to hold ‘fireside chats’ and have more power and institutional muscle around him, writes Richard Calland
Advertising

Subscribers only

Toxic power struggle hits public works

With infighting and allegations of corruption and poor planning, the department’s top management looks like a scene from ‘Survivor’

Free State branches gun for Ace

Parts of the provincial ANC will target their former premier, Magashule, and the Free State PEC in a rolling mass action campaign

More top stories

Q&A Sessions: ‘My north star is the patient’

Rhulani Nhlaniki is Pfizer’s cluster lead for sub-Saharan Africa. As Pfizer starts phase III of the clinical trial of their Covid-19 vaccine candidate, he tells Malaikah Bophela that if it is successful, the company will ensure the vaccine will be available to everyone who needs it

In terms of future-telling failures, this is a Major One

Bushiri knows how to pull a crowd. Ace knows a ponzi scheme. Paddy Harper predicts that a new prophet may profit at Luthuli House

Ghost fishing gear an ‘immortal menace’ in oceans

Lost and illegal tackle is threatening marine life and the lives of people making a living from the sea

Vitamin therapy is for drips

It may be marketed by influencers, but intravenous vitamin therapy is not necessary and probably not worth the hype, experts say
Advertising

press releases

Loading latest Press Releases…

The best local and international journalism

handpicked and in your inbox every weekday